Current Projects: The project focuses on developing remote home-based tDCS treatment that incorporates real-time Neuromap monitoring systems.

Our pioneering initiative targets remote home-based Transcranial Direct Current Stimulation (tDCS) treatment to develop more personalized, precise and effective neuromodulation therapies. The project utilizes real-time EEG data collection alongside AI-driven Neuromap analysis with ongoing patient monitoring to achieve clinical-level precision in home-based neuromodulation therapy.
Patients receiving tDCS treatment at home should have continuous supervision and protocol adjustments according to real-time neurophysiological data while tracking treatment effectiveness. Our advanced system combines EEG-BAND technology with Neuromap for uninterrupted brain function evaluation and dynamic treatment adjustments that use predictive analytics to improve therapy effectiveness.

Real-Time EEG Data Collection: The Key to Precision Neuromodulation

The traditional approach to tDCS treatment evaluation depends on periodic clinical assessments which result in treatment protocol adjustment delays and reduced chances for immediate optimization. Our home-based EEG-BAND technology allows families to perform daily EEG scans without difficulty to collect brainwave data throughout tDCS sessions.
The collection of real-time neurophysiological information enables us to continuously watch brain function and move away from periodic clinical evaluations. This means:

– This system provides daily observations of brain function alterations throughout tDCS treatment sessions.
– The system allows for the instant identification of therapy response trends which enables quick treatment adjustments to achieve better outcomes.
– The system offers monitoring capabilities for stress response together with attention spans and cognitive performance as well as emotional balance.

Neuromap system converts daily EEG readings into practical treatment adaptations.

Neuromap technology integration forms the foundation of this system’s power. Daily EEG data from each patient undergoes analysis through AI-based Neuromap algorithms to measure current brain activity against the baseline qEEX scan obtained before treatment initiation.
Neuromap identifies patterns and deviations in neural function alongside cognitive processing and emotional regulation to produce weekly reports which show treatment progress and recommend protocol adjustments when needed. These reports provide insights into:
– Monitoring attention levels involves the analysis of cognitive engagement changes and sustained focus development.
– The analysis of stress response examines both autonomic nervous system stability and emotional resilience capacities.
– The Learning Skill Adaptation process evaluates both cognitive plasticity and neural efficiency that adapts during treatment.
– The study evaluates how present tDCS settings affect specific areas of the brain.
The system prevents treatment stasis by replacing a static tDCS protocol with Neuromap’s real-time predictive adaptation and refinement of treatment plans.
Personalized Treatment Adaptation: Daily Adjustments for Maximum Results
Static neuromodulation protocols may fail to deliver optimal results because individual response rates vary widely. Through ongoing data collection combined with Neuromap-driven predictive modeling we have the ability to:
– Implement immediate changes to the tDCS stimulation procedure as required.
– Modify stimulation intensity, duration, and electrode placement in response to live brain function changes.
– Offer cognitive or relaxation tasks that align with real-time changes in brain neurophysiology.
– Treatment optimization for every patient should match the quality of care they would receive within a clinical environment.
When a patient receiving tDCS for attention enhancement exhibits decreased theta/beta ratios which indicate improved focus the settings for their stimulation should be adjusted slightly to preserve optimal brain function. When a stress-related biomarker goes up Neuromap often advises reducing stimulation intensity or adding relaxation protocols to the treatment regimen.

The treatment planning system dynamically modifies each tDCS session to achieve maximum results while providing patients with comprehensive clinical supervision during home treatment.
This system evolves home tDCS therapy to provide real-time clinical supervision.
We eliminated the main difficulty in home-based neuromodulation therapy which was the absence of real-time supervision. Home tDCS treatments frequently occur without patient access to daily clinical feedback.
– There is no assurance regarding the success of the treatment protocol.
– Inability to adjust protocols for faster improvement.
– Concerns about potential overstimulation or ineffective dosage.
Our system combines continuous EEG-BAND data with Neuromap’s AI analytics to enable daily supervision and optimization of tDCS therapy. Patients receive immediate feedback about their treatment because brain function is monitored and adjusted continuously in the same manner as treatment in a clinical neuromodulation center.